Riverview Trust Company’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,171	Closed	-$15.9K	–	313
2025 Q1	$15.9K	Buy	+1,171	New	+$15.9K	0.02%	520